shot-button
E-paper E-paper
Home > Sports News > Cricket News > Article > Former NZ captain McCullum admits testing positive during 2016 T20 Leagu

Former NZ captain McCullum admits testing positive during 2016 T20 Leagu

Updated on: 24 June,2018 11:59 AM IST  |  New Delhi (India)
PTI |

In the WADA list of 2016, there was one 'Adverse Analytical Finding' in cricket in India but BCCI never revealed the name

Former NZ captain McCullum admits testing positive during 2016 T20 Leagu

Brendon McCullum

Former Kiwis captain Brendon McCullum has admitted that he tested positive for a banned substance during the 2016 T20 but insisted that it was not a "failed drug test" as he had procured a retroactive Therapeutic Use Exemption certificate to clear his name.


In the WADA list of 2016, there was one 'Adverse Analytical Finding' in cricket in India but BCCI never revealed the name. According to a report in ESPN Cricinfo: "The former NZâu00c2u0080u00c2u0088captain has asthma and, in light of heavy pollution in Delhi at the time, he needed more than the usual dose of his medicine." "I certainly don't see it as a failed drug test. It was just a case of we just need to seek clarification and apply for this," McCullum told stuff.co.nz.


Catch up on all the latest sports news and updates here. Also download the new mid-day Android and iOS apps to get latest updates


This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK